These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 36204170)

  • 1. Self-administration of Psilocybin in the Setting of Treatment-resistant Depression.
    Lyons A
    Innov Clin Neurosci; 2022; 19(7-9):44-47. PubMed ID: 36204170
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Repetitive transcranial magnetic stimulation for the treatment of major depressive disorder: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2004; 4(7):1-98. PubMed ID: 23074457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Psychological therapies for treatment-resistant depression in adults.
    Ijaz S; Davies P; Williams CJ; Kessler D; Lewis G; Wiles N
    Cochrane Database Syst Rev; 2018 May; 5(5):CD010558. PubMed ID: 29761488
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder: A Randomized Clinical Trial.
    Davis AK; Barrett FS; May DG; Cosimano MP; Sepeda ND; Johnson MW; Finan PH; Griffiths RR
    JAMA Psychiatry; 2021 May; 78(5):481-489. PubMed ID: 33146667
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A clinical approach to treatment resistance in depressed patients: What to do when the usual treatments don't work well enough?
    Dodd S; Bauer M; Carvalho AF; Eyre H; Fava M; Kasper S; Kennedy SH; Khoo JP; Lopez Jaramillo C; Malhi GS; McIntyre RS; Mitchell PB; Castro AMP; Ratheesh A; Severus E; Suppes T; Trivedi MH; Thase ME; Yatham LN; Young AH; Berk M
    World J Biol Psychiatry; 2021 Sep; 22(7):483-494. PubMed ID: 33289425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Psilocybin-assisted psychotherapy for depression: Emerging research on a psychedelic compound with a rich history.
    Pearson C; Siegel J; Gold JA
    J Neurol Sci; 2022 Mar; 434():120096. PubMed ID: 34942586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The use of psilocybin for treatment-resistant depression].
    Johannesdottir A; Sigurdsson E
    Laeknabladid; 2022 Sep; 108(9):403-410. PubMed ID: 36040772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Single-dose psilocybin for a treatment-resistant episode of major depression: Impact on patient-reported depression severity, anxiety, function, and quality of life.
    Goodwin GM; Aaronson ST; Alvarez O; Atli M; Bennett JC; Croal M; DeBattista C; Dunlop BW; Feifel D; Hellerstein DJ; Husain MI; Kelly JR; Lennard-Jones MR; Licht RW; Marwood L; Mistry S; Páleníček T; Redjep O; Repantis D; Schoevers RA; Septimus B; Simmons HJ; Soares JC; Somers M; Stansfield SC; Stuart JR; Tadley HH; Thiara NK; Tsai J; Wahba M; Williams S; Winzer RI; Young AH; Young MB; Zisook S; Malievskaia E
    J Affect Disord; 2023 Apr; 327():120-127. PubMed ID: 36740140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparative study of the effect of electroconvulsive therapy and transcranial direct current stimulation in the treatment of persons suffering from treatment-resistant depression.
    Ramasubramanian V; Mathumathi S; Rajendhiran G; Bijulakshmi P; Kannan M
    Ind Psychiatry J; 2022; 31(1):68-73. PubMed ID: 35800872
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dextroamphetamine-Amphetamine Augmentation in the Treatment of Treatment-Resistant Depression.
    Small TM; Dhat S; Faruqui Z
    Cureus; 2022 Aug; 14(8):e27755. PubMed ID: 36106259
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized controlled trial of a standard 4-week protocol of repetitive transcranial magnetic stimulation in severe treatment resistant depression.
    van Eijndhoven PFP; Bartholomeus J; Möbius M; de Bruijn A; Ferrari GRA; Mulders P; Schene AH; Schutter DJLG; Spijker J; Tendolkar I
    J Affect Disord; 2020 Sep; 274():444-449. PubMed ID: 32663974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurostructural Differences in Adolescents With Treatment-Resistant Depression and Treatment Effects of Transcranial Magnetic Stimulation.
    Seewoo BJ; Rodger J; Demitrack MA; Heart KL; Port JD; Strawn JR; Croarkin PE
    Int J Neuropsychopharmacol; 2022 Aug; 25(8):619-630. PubMed ID: 35089358
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Confirmatory Efficacy and Safety Trial of Magnetic Seizure Therapy for Depression (CREST-MST): study protocol for a randomized non-inferiority trial of magnetic seizure therapy versus electroconvulsive therapy.
    Daskalakis ZJ; Tamminga C; Throop A; Palmer L; Dimitrova J; Farzan F; Thorpe KE; McClintock SM; Blumberger DM
    Trials; 2021 Nov; 22(1):786. PubMed ID: 34749782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trial of Psilocybin versus Escitalopram for Depression.
    Carhart-Harris R; Giribaldi B; Watts R; Baker-Jones M; Murphy-Beiner A; Murphy R; Martell J; Blemings A; Erritzoe D; Nutt DJ
    N Engl J Med; 2021 Apr; 384(15):1402-1411. PubMed ID: 33852780
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness of transcranial magnetic stimulation in clinical practice post-FDA approval in the United States: results observed with the first 100 consecutive cases of depression at an academic medical center.
    Connolly KR; Helmer A; Cristancho MA; Cristancho P; O'Reardon JP
    J Clin Psychiatry; 2012 Apr; 73(4):e567-73. PubMed ID: 22579164
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unraveling the Mysteries of Mental Illness With Psilocybin.
    Sotille R; Singh H; Weisman A; Vida T
    Cureus; 2022 May; 14(5):e25414. PubMed ID: 35769681
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of Treatment-Resistant Depression: Challenges and Strategies.
    Voineskos D; Daskalakis ZJ; Blumberger DM
    Neuropsychiatr Dis Treat; 2020; 16():221-234. PubMed ID: 32021216
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Repetitive Transcranial Magnetic Stimulation for People With Treatment-Resistant Depression: A Health Technology Assessment.
    Ontario Health (Quality)
    Ont Health Technol Assess Ser; 2021; 21(4):1-232. PubMed ID: 34055112
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Psilocybin with psychological support for treatment-resistant depression: six-month follow-up.
    Carhart-Harris RL; Bolstridge M; Day CMJ; Rucker J; Watts R; Erritzoe DE; Kaelen M; Giribaldi B; Bloomfield M; Pilling S; Rickard JA; Forbes B; Feilding A; Taylor D; Curran HV; Nutt DJ
    Psychopharmacology (Berl); 2018 Feb; 235(2):399-408. PubMed ID: 29119217
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Utility of repetitive transcranial stimulation as an augmenting treatment method in treatment-resistant depression.
    Jhanwar VG; Bishnoi RJ; Jhanwar MR
    Indian J Psychol Med; 2011 Jan; 33(1):92-6. PubMed ID: 22021964
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.